Table 4.
Effects of gabexate mesilate on the outcome of the patients
Survivors | Nonsurvivors | Mortality (%) | P value | |
---|---|---|---|---|
Gabexate mesilate and antithrombin |
14 |
2 |
12.5 |
|
Gabexate mesilate |
15 |
2 |
11.8 |
|
|
|
|
|
1.000 |
Use of gabexate mesilate |
29 |
4 |
12.1 |
|
Nonuse of gabexate mesilate |
24 |
3 |
11.1 |
|
1.000 |